Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
| Company Name | Founded | Funding Stage | Amount | City |
|---|---|---|---|---|
| Immunic Therapeutics | 2026 | Post Ipo Equity | $400.0M | New York |
| Coherus Biosciences | 2026 | Post Ipo Equity | $50.1M | Redwood City |
| Evommune | 2026 | Post Ipo Equity | $125.0M | Palo Alto |
| Xilio Therapeutics | 2026 | Post Ipo Equity | $40.0M | Waltham |
| Angitia Biopharmaceuticals | 2026 | Series D | $130.0M | Westlake Village |
| Apeiron labs | 2026 | Series A | $9.5M | Cambridge |
| Avalanche Energy | 2026 | Series Unknown | $29.0M | Seattle |
| Vaxcyte | 2026 | Post Ipo Equity | $632.5M | San Carlos |
| Nautilus Biotechnology | 2026 | Grant | $1.6M | San Carlos |
| CORXEL Pharmaceuticals | 2026 | Series D | $287.0M | Shanghai |
| # | Company | Stage | Amount | Location |
|---|---|---|---|---|
| 176 | Immunic Therapeutics | Post Ipo Equity | $400.0M | New York, United States |
| 177 | Coherus Biosciences | Post Ipo Equity | $50.1M | Redwood City, United States |
| 178 | Evommune | Post Ipo Equity | $125.0M | Palo Alto, United States |
| 179 | Xilio Therapeutics | Post Ipo Equity | $40.0M | Waltham, United States |
| 180 | Angitia Biopharmaceuticals | Series D | $130.0M | Westlake Village, United States |
| 181 | Apeiron labs | Series A | $9.5M | Cambridge, United States |
| 182 | Avalanche Energy | Series Unknown | $29.0M | Seattle, United States |
| 183 | Vaxcyte | Post Ipo Equity | $632.5M | San Carlos, United States |
| 184 | Nautilus Biotechnology | Grant | $1.6M | San Carlos, United States |
| 185 | CORXEL Pharmaceuticals | Series D | $287.0M | Shanghai, China |
Immunic is a biopharmaceutical company that develops a pipeline of selective oral immunology therapies.
Coherus Biosciences develops, manufactures, and commercializes biologic therapeutics for oncology and inflammatory diseases.
Evommune is a biotechnology company that develops therapeutics that halt progressive disease and address their symptoms.
Xilio Therapeutics is a biotechnology company that develops tumor-activated immuno-oncology therapies.
Angitia Biopharmaceuticals develops biologic therapies for musculoskeletal diseases.
Apeiron labs mission is to provide data from the upper of the ocean.
Avalanche Energy is a fusion energy startup that develops micro-fusion reactors for distributed energy and mobility.
Vaxcyte focuses on developing vaccines designed to prevent or treat some of the most common and deadly infectious diseases worldwide.
Nautilus Biotechnology is a life sciences company that develops a platform for analyzing and quantifying the human proteome.
CORXEL Pharmaceuticals is a biotechnology company that develops science and medicines for underserved patients.
BioAge Labs is a clinical-stage biotechnology company that develops therapeutics to treat obesity and metabolic diseases.
Kinaset Therapeutics is a biopharma company that focuses on advancement of novel drugs in areas of unmet medical needs.
Century Therapeutics is a biotechnology company that develops cell therapies for hematological and solid tumor malignancies.
Parabilis Medicines is a Grupo Bugio is a biopharmaceutical firm that specializes in creating medicines.
Diagonal Therapeutics is a biotechnology startup that develops targeted therapies for cancer and genetic diseases.
EvodiaBio is a bio-industrial firm that creates natural, sustainable scents for the food and beverage industries.
Ambros Therapeutics is a clinical-stage biotechnology company.
Jade Biosciences is developing transformative therapies to redefine the standard of care for inflammation and immunology indications.
Tenaya Therapeutics a clinical-stage biotechnology company that develops novel therapies to treat heart diseases.
Sidera Bio harness human genetics, that helps in transformative medicines for patients.
Dyne Therapeutics is a developer of targeted therapies intended for serious muscle diseases.
Wave Life Sciences is a clinical-stage RNA medicines company committed to delivering life-changing treatments for people battling diseases
Triana Biomedicines is a developer of a molecular glue discovery platform to regulate disease.
Belite Bio is a clinical stage biopharmaceutical drug development company.
Artios Pharma is a biopharmaceutical company that provides new solutions in the DNA damage response (DDR) field.
RA Capital Management has invested in 369 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
RA Capital Management's top investment sectors include Biotechnology, Health Care, Therapeutics, Medical, Biopharma. The firm invests across 17 different industry categories.
Among tracked funding rounds, Vaxcyte received $632.5M in a Post Ipo Equity round. RA Capital Management's total known invested capital is $19.0B.
RA Capital Management's average investment size is $91.5M across its portfolio of 369 companies.
Recent RA Capital Management portfolio additions include Immunic Therapeutics, Coherus Biosciences, Evommune, Xilio Therapeutics, Angitia Biopharmaceuticals. These companies were founded in 2020 or later.
Discover portfolio companies of other leading venture capital firms and investors.
View All Investors